Silence Therapeutics reported $17.38M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AstraZeneca USD 34.05B 518M Sep/2025
Autolus Therapeutics Ltd USD 83.07M 14.92M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Novartis USD 32B 286M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Silence Therapeutics USD 17.38M 2.61M Sep/2025